Brinker Capital Investments, LLC Dr Reddys Laboratories LTD Transaction History

Brinker Capital Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$59.5 - $67.25 $2.32 Million - $2.63 Million	-39,058 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$62.12 - $74.2 $340,790 - $407,061	5,486 Added 16.34%	39,058 $2.87 Million
Q1 2021 May 12, 2021	BUY	$57.98 - $73.08 $1.95 Million - $2.45 Million	33,572 New	33,572 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $886,119 - $1.01 Million	-14,153 Closed	0 $0
Q3 2020 Dec 03, 2020	BUY	$51.39 - $72.41 $727,322 - $1.02 Million	14,153 New	14,153 $987,000

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.